Alectinib M1b Metabolite
Alectinib M1b Metabolite is a minor metabolite of Alectinib that is a small-molecule ALK inhibitor utilized in the treatment of patients suffering from ALK-positive unresectable, recurrent/advanced Non-small cell lung cancer.
Additional information on Alectinib M1b Metabolite
Catalogue No.
VL5710007
CAS No.
N/A
Molecular Formula
C₃₀H₃₄N₄O₄
Molecular Weight
514.62 g/mol
Parent drug
Alectinib
IUPAC Name
2-((1-(3-cyano-9-ethyl-6, 6-dimethyl-11-oxo-6, 11-dihydro-5H-benzo[b]carbazol-8-yl)piperidin-4-yl)(2-hydroxyethyl)amino)acetic acid
Synonyms
N/A
References
Sato-Nakai, Mika, et al. “Metabolites of Alectinib in Human: Their Identification and Pharmacological Activity.” Heliyon, vol. 3, no. 7, July 2017, p. e00354, https://doi.org/10.1016/j.heliyon.2017.e00354.
Status
In-stock
